Brian Walker

Professor Brian Walker, a co-founder of ProAxsis Ltd., has over 30 years of experience in the design and synthesis of “Protease-Tags” for the identification and validation of protease targets of biomedical and pharmaceutical importance. He is a highly experienced researcher with an extensive track record of seminal research publications in Protease Inhibitor Innovation and Development. He has trained over 70 PhD candidates, has served on major national and international funding bodies and has been responsible for initiating significant Technology Transfer Programs with leading International Pharma and Biotech companies. He is responsible for the continued development and expansion of the ProteaseTagTM portfolio for commercial use.

Brian is a graduate of Queen’s University Belfast (QUB), where he obtained a BSc in Chemistry followed by a PhD in Biochemistry, the latter being funded through the award of a prize Fellowship in Basic Clinical Sciences. After completing a postdoctoral position in the Friedrich Miescher Institute in Basel, he returned to Belfast to take up a Lectureship in Biochemistry. He was subsequently appointed to a Personal Chair in Biochemistry within the School of Biological Sciences, before being appointed to the McClay Chair in Biomedicinal Chemistry, in the School of Pharmacy at QUB, in September 1998.

Brian Walker

CSO
Brian Walker
Dr David Ribeiro

Dr David Ribeiro

CEO
Dr Ribeiro has extensive experience in commercialising products within chronic diseases, having previously held senior management roles at Solvay Healthcare, Encysive Pharmaceuticals and Pfizer.
Read More
François Martelet

François Martelet

Chairman
François Martelet brings over 20 years of biopharma experience and a proven track record of shaping and developing businesses to deliver returns. He has broad
Read More
Ian Postlethwaite

Ian Postlethwaite

Non-executive Director
Ian Postlethwaite brings over 14 years of biopharma experience and a proven track record of driving revenue growth and funding development programs. He has broad
Read More
David Moore

David Moore

Head of Spin Outs & Investments, QUBIS Ltd.
David is Investment Manager with QUBIS Ltd, the early stage investment fund responsible for the commercialisation of technology from The Queen’s University of Belfast.
Read More
Lorraine Martin

Lorraine Martin

Non-executive Director
Dr Lorraine Martin is a co-founder of ProAxsis Ltd. and a Senior Lecturer in Molecular Pharmaceutics within the School of Pharmacy, Queen’s University Belfast.
Read More
Ernest Schneider

Ernest Schneider

Non-executive Director
Ernest Schneider is a solicitor, patent & trade mark attorney and accredited mediator. He is the Commercial-Legal Director and Company Secretary of NetScientific plc and
Read More